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http:WHAT THIS PAPER ADDS
This is, to our knowledge, the ﬁrst prospective interdisciplinary study of diabetic patients with ischemic foot
ulcers, considered not feasible for revascularization followed and treated to outcome. The study examines
outcome and factors that are strongly related to outcome in these patients. The study showed that these
patients are not excluded from healing without major amputation. Factors strongly related to outcome were co-
morbidity, severity of PAD, and extent of tissue destruction. Findings in this study reinforce the need for a
classiﬁcation system considering factors at the decision making for vascular intervention.Objective/background: There is limited information regarding outcome in patients not available for
revascularisation. Our aim was to identify factors related to ulcer healing in diabetic patients with severe
peripheral arterial disease who were not available for revascularisation.
Methods: Diabetic patients with a foot ulcer, consecutively presenting at a multidisciplinary foot centre with
systolic toe pressure <45 mmHg or an ankle pressure <80 mmHg were prospectively included. Patients who
received revascularisation were excluded. All patients had continuous follow-up until healing or death.
Results: Out of 602 patients (median age: 76 years) included in this study, 50% healed either primarily (76%) or
with a minor amputation (24%). Seventeen percent of patients healed after major amputation and 33% died
unhealed. By regression analysis, rest pain, impaired renal function, ischemic heart disease, cerebral vascular
disease, extent of tissue destruction, and ankle pressure >50 mmHg affected the outcome of the ulcers.
Conclusion: Diabetic patients with ischemic foot ulcers not available for revascularisations are not excluded from
healing without major amputation. Factors strongly related to outcome were co-morbidity, severity of peripheral
arterial disease, and extent of tissue destruction. Our ﬁndings reinforce the need for a classiﬁcation system
considering these factors at decision-making for vascular intervention.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The diabetic foot ulcer is a heterogeneous disease that
continues to be a major problem for the patient and for the
healthcare system. Besides the risk of complications, such as
infection or amputation,1 diabetic foot ulcer disease has a
major effect on patients’ economical and social life.2 Major
amputations of lower extremities have been shown to
predict reduced quality of life3 and re-amputation,4 as well
as mortality,5 in diabetic patients with foot ulcer.responding author. T. Elgzyri, Department of Endocrinology, Skåne
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//dx.doi.org/10.1016/j.ejvs.2013.04.013Peripheral arterial disease (PAD) and concurrent co-
morbidities have been shown to be signiﬁcant predictors of
ulcer healing in diabetic patients.6e11 PAD is considered to be
the most important limiting factor for healing of ischemic
diabetic foot ulcers.1,12,13 The majority of studies on ischemic
foot ulcer include both diabetic and non-diabetic patients,
and examines the rate of limb salvage improvement after
revascularization, rather than ulcer healing as an outcome.14
There are few studies that examine foot ulcer and PAD in
diabetic patients only.6,15,16 One study on patients with
critical limb ischemia, without vascular interventions,
showed that 54% of legs survived at 1 year.17 However, to our
knowledge, there are no studies that examine factors that
affect ulcer healing in diabetic patients with ischemic foot
ulcer in the absence of invasive vascular intervention. The
aim of this study was to examine the outcome and identify
factors related to healing of foot ulcers in diabetic patients
with severe PAD not receiving revascularization.
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Study population
Consecutively presenting patients with diabetes and
ischemic/neuroischemic foot ulcer (Wagner grade 1e5, at
or below the ankle) admitted to a multidisciplinary foot
centre between 1984 and 2006 (n ¼ 1151; Fig. 1) were
treated and followed up according to a standardized pro-
tocol until healing or death. The patients’ data were pro-
spectively recorded. The study was approved by the local
ethics committee. In 602 patients no revascularization
(angioplasty or reconstructive vascular surgery) was per-
formed. These 602 patients were included in the present
study. All patients continued with conservative treatment at
the diabetic foot clinic according to their programme.Inclusion criteria
Individuals with diabetes mellitus and foot ulcer, and a
systolic toe pressure <45 mmHg, a systolic ankle pressure
<80 mmHg, or, in the case of non-measurable pressure
levels, non-palpable foot pulses with an ulcer Wagner grade
4e5 or rest pain. All patients fulﬁlled Fontaine grade 4.18Study design
Patients were followed and treated according to a preset
standardized protocol by a multidisciplinary team both in
and out of hospital until healing with or without amputa-
tion was achieved, or until the patient died with an un-
healed ulcer. All lesions were assessed and documented by
the same team. Outpatient treatment was carried out in
collaboration with primary healthcare and home nursing
services. Physical examination of the foot was performed at
inclusion and regularly during the study by the multidisci-
plinary team.
The core team consisted of a diabetologist, an orthopedic
surgeon, an orthotist, a podiatrist, and a registered nurse
educated in diabetes. Vascular investigation was carried out
according to a prescheduled programme by a vascular sur-
geon integrated in the team on a regular basis. Systolic toe
and ankle blood pressure was measured using strain gauge
and Doppler techniques at the vascular laboratory.19
All data were recorded on standardized case record
forms; these forms were both computerized and trans-
formed into ﬁles. At study entry data were collected on
previous management, referral, patient characteristics, co-
morbidities, ulcer characteristics, and laboratory
investigations.
Each patient was represented by one lesion below the
ankle. Patients with several concurrent lesions were rep-
resented by the one with the worst outcome. Patients with
three or more ulcers on the same foot were classiﬁed as
having multiple ulcers. The most superﬁcial ulcer included
was a full thickness skin ulcer penetrating into the subcu-
taneous layer. The Wagner grade at inclusion and the
maximal Wagner grade reached were recorded. Minor
gangrene describes Wagner grade 4; major gangrene de-
scribes Wagner grade 5.The patients were treated as outpatients, but in the case
of deep infection associated with septic condition, foot
surgery, amputations, or exacerbation of inter-current dis-
ease they were treated as inpatients under the supervision
of the foot team.
Patients were offered medical, surgical, and topical
treatment, as well as ofﬂoading as needed.6 All patients
were followed up by the team according to protocol until a
ﬁnal outcome: primary healing, healing after minor or major
amputation, or death unhealed.Angiography
Angiography was performed at the discretion of a vascular
surgeon according to a written programme that was jointly
agreed upon. A retrograde aorto-femoral angiography,
routinely visualizing distal vessels, as well as the pedal
arch, was performed if the medical condition allowed and
if informed consent was given. The catheter was placed as
far distally as possible, and delayed and magniﬁed lateral
foot views were routinely obtained. This study includes
patients who did not have an angiography or were not
available for further vascular intervention following
angiography.
Exclusion criteria for angiography were:
 medical condition not allowing angiography
 extensive gangrene (Wagner grade 5)
 major amputation performed prior to angiography
 subjective life expectancy of the patient <6 months
 signs of ulcer healing before angiography could be
performed
 lack of walking capacity prior to occurrence of ulcer,
restitution not expected
 informed consent for angioplasty refused.
All patients undergoing angiography were treated ac-
cording to a programme regarding hydration and choice of
pharmaceutical drugs to avoid renal failure.20 All reasons for
not performing vascular intervention after angiography
were registered. Only one reason for each patient, the one
most conclusive for the decision, is mentioned. All patients
were treated with acetylsalicylic acid or clopidogrel, used
since 1998, if no contraindication was present.Statistics
Values are given as median and range. Comparisons be-
tween groups were made using the ManneWhitney or chi-
square test. Statistical signiﬁcance was deﬁned as a p-value
<.05. The simultaneous inﬂuence of possible risk factors on
a binary outcome (primary healing or minor amputation vs.
major amputation or unhealed) was investigated by means
of backward logistic regression analysis where all variables
with a p-value <0.15 were included in the ﬁnal model.
Survival curves were plotted using KaplaneMeier analysis
and statistical signiﬁcance was determined by log-rank test.
Statistical analysis was performed using SPSS statistics 20
(SPSS, Chicago, IL, USA).
Outcome No angiography          
n = 319 (53%) 
Angiography without 
intervention 
n = 283 (47%) 
Total 
n 602 (100%) 
Ongoing ulcer 2 (—) 2 (—) 4 (—) 
Primary healing 119 (37) 108 (38) 227 (38) 
Healed after minor 
amputation 
34 (11) 38 (13) 72 (12) 
Healed after major 
amputation 
40 (13) 61 (22) 101 (17) 
Deceased unhealed 
with/without amputation 
123 (38) 74 (26) 197 (33) 
)—(1)—(0)—(1tuoporD
Drop out = 5 n = 1151 
Joined session with 
vascular surgeon 
Toe and ankle blood 
pressure measurement 
Angiography with vascular 
intervention 
n = 544 (excluded)
No vascular intervention 
n = 602 
Ankle pressure <80 mmHg, or 
Toe pressure <45 mmHg, or 
non-papable foot pulse with rest pain or Wagner grade 4-5 
Diabetic patients with foot ulcer 
Figure 1. Flow chart of the study population and outcome with regard to angiography performance.
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Six hundred and two patients were included (one dropped
out prior to angiography) and continued follow up in the
study (30 weeks, [1e276]). Thirty-four patients had been
taken over for routine management by other units before a
ﬁnal outcome was reached. The Swedish system, owing to
its geographical responsibilities and reimbursement system,
makes it possible to follow up patients until a speciﬁc end
point, irrespective of the care provider. Outcome is not
known in the only drop out patient. The outcome of the
other 33 patients could be collected from medical records
from other units. Patients were of older age (median 76
years, range 36e95 years), predominantly men (60%), with
a median duration of diabetes of 15 years (range 0e61years) and 16% were current smokers (Table 1). Intermit-
tent claudication was present in 19% of patients, rest pain
in 39%, and peripheral edema in 55%. A systolic toe pres-
sure <45 mmHg and an ankle pressure <80 mmHg were
seen in 79% and 54% of patients respectively. At inclusion,
26% of the patients had deep ulcer of Wagner grade 3
compared with 53% during follow-up. Forty-two percent of
all patients had the Wagner grade of an ulcer progress
(ulcer progression) during the follow-up time.Angiography versus no angiography
In 319 patients (53%) no angiography was performed ac-
cording to protocol, while 283 patients had an angiography.
Patients who underwent angiography were younger
Table 1. Clinical characteristics.
No angiography
(n ¼ 319)
Angiography
(n ¼ 283)
p1 Patients healed
after major
amputation or
deceased
unhealed
(n ¼ 303)
Patients with
healed
ulcera (n ¼ 299)
p2 All
(n ¼ 602)
Males 58% (186) 62% (176) 0.395 59% (179) 61% (183) 0.618 60% (362)
Age (y) 78 (36e95) 75 (39e95) 0.017 79 (39e95) 74 (36e95) <0.001 76 (36e95)
Age at diagnosis (y) 61 (0e89) 59 (0e91) 0.298 62 (0e91) 57 (0e89) 0.001 60 (0e91)
Diabetes duration (y) 15 (0e61) 15 (0e60) 0.859 15 (0e60) 15 (0e61) 0.507 15 (0e61)
HbA1c (%) 7.3 (4.3e14.0) 7.4 (3.6e15.0) 0.617 7.0 (4.2e13.0) 8.0 (3.6e15.0) <0.001 7.4 (3.6e15.0)
Serum creatinine (mmol/L) 94 (31e996) 91 (46e755) 0.445 102 (43e996) 88 (31e772) <0.001 93 (31e996)
Systolic BP (mmHg) 150 (90e240) 150 (70e225) 0.317 150 (70e225) 150 (90e240) 0.317 150 (70e240)
Ankle pressure (mmHg) 80 (0e235) 80 (20e250) 0.530 70 (0e250) 90 (20e230) <0.001 80 (0e250)
Ankle pressure 50
(mmHg)
10% (31) 11% (31) 0.414 14% (42) 7% (20) 0.003 10% (62)
Toe pressure (mmHg) 35 (0e125) 30 (0e90) 0.565 30 (0e125) 35 (0e125) 0.022 35 (0e125)
Toe pressure 30
(mmHg)
47% (150) 50% (142) 0.356 52% (156) 46% (136) 0.118 50% (292)
Current smokers 16% (51) 17% (47) 0.783 18% (53) 14% (43) 0.317 16% (96)
Retinopathy 45% (143) 54% (153) 0.922 42% (128) 56% (168) 0.376 49% (296)
Nephropathy 33% (106) 35% (99) 0.606 33% (99) 36% (106) 0.492 34% (205)
Intermittent claudication 15% (47) 23% (65) 0.012 21% (62) 17% (50) 0.251 19% (112)
Rest pain 31% (100) 48% (135) <0.001 51% (153) 27% (82) <0.001 39% (235)
Peripheral oedema 55% (175) 55% (155) 0.868 61% (184) 49% (146) 0.005 55% (330)
IHD 43% (137) 47% (133) 0.326 55% (165) 35% (105) <0.001 45% (270)
CHF 30% (97) 28% (79) 0.530 37% (112) 21% (64) <0.001 29% (176)
CVD 42% (134) 31% (87) 0.005 47% (141) 27% (80) <0.001 37% (221)
Ulcer Wagner grade 3 28% (88) 25% (71) 0.518 26% (80) 26% (79) 0.529 26% (159)
Max. ulcer Wagner
grade 3
49% (155) 58% (163) 0.031 60% (182) 46% (136) <0.001 53% (318)
Superﬁcial ulcer 48% (153) 44% (123) 0.288 43% (131) 49% (145) 0.220 46% (276)
Deep ulcer 24% (78) 31% (88) 0.068 30% (91) 25% (75) 0.172 28% (166)
Abscess/osteitis 16% (50) 12% (34) 0.239 8% (23) 20% (61) <0.001 14% (84)
Minor gangrene 10% (33) 12% (35) 0.441 17% (50) 6% (18) <0.001 11% (68)
Major gangrene 2% (5) 1% (2) 0.457 2% (7) 0% (0) 0.015 1% (7)
Ulcer progressorsb 38% (119) 47% (132) 0.024 49% (148) 34% (103) <0.001 42% (251)
Note. Data are % (n) or median (range). Bold values denote signiﬁcance. p1 ¼ angiography vs. no angiography. p2 ¼ healed vs. unhealed;
y ¼ years; HbA1c ¼ glycosylated hemoglobin; BP ¼ blood pressure; IHD ¼ ischemic heart disease; CHF ¼ Congestive heart failure;
CVD ¼ cerebrovascular disease.
a Primary healing or after minor amputation.
b Progress in Wagner’s grade during follow up.
T. Elgzyri et al. 113(p ¼ .017) and had less cerebrovascular disease (p ¼ .005),
but more frequently had rest pain (p < .001), intermittent
claudication (p ¼ .012), maximal Wagner ulcer grade 3
prior to outcome (p ¼ .031) and signs of ulcer progression
(p¼ .024) (Table 1), and underwentmoremajor amputations
during follow up (p ¼ .019) (Fig. 1). There was no signiﬁcant
statistical difference in healing rate between the groups.
Outcome
Primary healing was seen in 38% of patients, corresponding
to 56% of the surviving patients. Seventy-four percent of
the surviving patients healed without major amputation.
Four patients still had an on-going ulcer by the end of the
study. Median time for healing without major amputation
was 27 weeks (1e276 weeks). Seventeen percent of the
patients required a major amputation before healing(Fig. 1). This was more common following an angiography
than without one (p ¼ .009). Thirty-three percent of pa-
tients died unhealed. Median time until death was 29
weeks (1e256): 24 weeks (1e156) for those without angi-
ography and 47 weeks (1e256) for those who had angi-
ography. Thirty-four patients had minor amputation
followed by major amputation or death before healing. In
these cases the outcome considered is major amputation or
death. Similarly, 13 patients died with unhealed major
amputation. Twenty patients had non-measurable ankle
pressure and toe pressure 45 mmHg. Among these pa-
tients, four patients healed primarily, six patients healed
after minor amputation, two patients healed after major
amputation, and eight patients died unhealed.
A multiple regression analysis with all patients was per-
formed, including demographic data, clinical characteristics,
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related to primary healing or healing after minor amputa-
tion (Table 2). Rest pain, ankle pressure, co-morbidity
(ischemic heart disease, cerebrovascular disease, and
renal function impairment), and maximal extent of tissue
destruction were related to probability of healing.
A similar regression analysis among surviving patients
(Table 2) showed that the same factors (rest pain, severity
of peripheral arterial disease, ischemic heart disease, ce-
rebrovascular disease, and maximal extent of tissue
destruction), with the exception of renal function impair-
ment, were also related to the probability of healing in this
group.
KaplaneMeier survival analysis was used to display sur-
vival curves for the factors that affected healing according
to regression analysis shown in Table 2. Rest pain
(p < .001), ankle pressure (p < .001) (Fig. 2A and B),
ischemic heart disease (p < .001), cerebrovascular disease
(p < .001), and renal function test (p ¼ .025), but not
extent of tissues destruction showed signiﬁcant relation to
healing over time.
Outcome in relation to reason why no vascular
intervention was performed
Deteriorated general condition of the patient (n ¼ 166),
lack of patient consent to angiography and further inter-
vention (n ¼ 100), and signs of ulcer healing (n ¼ 98) were
the most common reasons why no angiography or further
vascular intervention was performed (Table 3). Fourteen
patients had all arteries open in the lower leg on angiog-
raphy despite the inclusion criteria. Thirteen patients out of
these fourteen patients had a toe pressure <45 mmHg; two
of them had non-measurable ankle pressure. Patients with
signs of healing (n ¼ 98) or open arteries on angiography
(n ¼ 14) all healed without major amputation, with the
exception of one patient who died unhealed. Of patients
with deteriorated general condition prior to or after angi-
ography (n ¼ 166), lack of vein graft (n ¼ 10), and ulcer
location (n ¼ 6) as a reason for not performing vascular
intervention, 78% required a major amputation or died
unhealed. When vascular intervention was not possible
according to angiography (n ¼ 60), 43% of patients healed
without major amputation. Among those who did not give
consent for angiography (n ¼ 100) or those with no walking
capacity (n ¼ 60), healing without major amputation was
seen in 59% and 55% of these patients respectively.Table 2. Factors related to ulcer healing.
All patients
OR (95% CI)
Pain at rest 0.59 (0.38e0.91)
Ankle pressure >50 mmHg 2.44 (1.27e4.66)
Serum creatinine >130 mmol/L 0.55 (0.34e0.88)
Ischemic heart disease 0.52 (0.34e0.81)
Cerebrovascular disease 0.41 (0.27e0.64)
Max. Wagner grades 3 reached 0.51 (0.33e0.77)
Note. Healing refers to primary healing or healing after minor amputatiDISCUSSION
This is, to our knowledge, the ﬁrst prospective interdisci-
plinary study of diabetic patients with ischemic foot ulcers
considered not feasible for revascularization followed and
treated to outcome. Factors strongly related to probability
of healing without a major amputation despite no revas-
cularization were severity of PAD, co-morbidity, and extent
of tissue destruction. In this study a primary healing rate of
38% was achieved with a corresponding primary healing
rate of 56% in surviving patients. The corresponding healing
rate for healing below the ankle (including minor amputa-
tions) was 50% and 74% respectively. Seventeen percent of
patients healed after major amputation and 33% of the
patients died unhealed.
This should be seen in the perspective of previously
published studies. In our study, patients were treated
conservatively, as revascularization was not performed
owing to various reasons. There is a limited number of
studies that have examined diabetic patients with ischemic
foot ulcer without vascular intervention. Lepäntalo et al.17
have previously shown, in patients with critical limb
ischemia without vascular reconstruction, that mortality at
1 year in these patients was 46% and limb survival at 1 year
was 54%. In another study, where patients with PAD and
foot ulcer were treated conservatively, major amputation at
1 year was done in 23% of patients.21 However, both studies
included non-diabetic patients. In a systematic review of
the effect of revascularization in diabetic patients with
ischemic foot ulcers, median mortality after reconstructive
surgery was 13.5% at 1 year and 46.5% at 5 years. However,
in some of the studies included in this review, up to 20% of
patients may not have had a foot ulcer, and the results did
not exclude these patients.14
In the present study, co-morbidity, severity of arterial
insufﬁciency, extent of tissue destruction, and rest pain
were related to lower probability of ulcer healing. The
presence of foot ulcers in individuals with diabetes has to
be recognized as a sign of multi-organ disease, which is
conﬁrmed by a number of studies.6,22,23 Diabetic patients
with lower limb ischemia have been shown to have more
chronic renal disease and a history of myocardial infarction
compared with non-diabetic patients.24 One study has
shown that cardiac disease is common in diabetic patients
with chronic foot ulcer where 76% of patients without a
previous history of heart disease had signs of cardiac muscle
dysfunction.25 Patients with diabetic foot problems havep Surviving patients p
OR (95% CI)
0.016 0.34 (0.14e0.81) <0.0001
0.007 3.73 (1.41e9.88) 0.008
0.012 0.56 (0.27e1.17) NS
0.004 0.47 (0.23e0.94) 0.033
<0.001 0.43 (0.21e0.86) 0.017
0.002 0.08 (0.03e0.20) <0.001
on. OR ¼ odds ratio; CI ¼ conﬁdence interval; NS ¼ not signiﬁcant.
Figure 2. Healing probability (patients survival free from major amputation) in relation to (A) rest pain and (B) ankle pressure (mmHg). The
number of patients at risk is shown in the tables.
T. Elgzyri et al. 115been shown to have a higher prevalence of cerebrovascular
accidents and a higher incidence of new cerebrovascular
accidents compared with diabetic patients without foot
ulcer.26 Furthermore, kidney disease is also associated with
worse outcome in diabetic foot problem.27e29
Our study’s design was based on non-invasive examina-
tions to evaluate possibilities for vascular intervention in
diabetic patients with ischemic foot ulcers. Assessment of
the need for vascular intervention in diabetic patients with
ischemic or neuroischemic foot ulcers has frequently been
based on the presence of symptoms in these patients or the
extent of tissue loss. In this study, regression analysis
showed that the presence of rest pain affects the outcome
of ischemic foot ulcer in diabetic patients. However, rest
pain and claudication in individuals with diabetic foot ulcers
are substantially less frequent than in individuals with
ischemia without diabetes.30 In the present study, 42% ofTable 3. Outcome of foot ulcers in relation to reason for no angiograp
Ongoing
ulcer
Healed
primarily
Hea
amp
Lack of consent d 43 (43) 16
General condition not allowing 1 (1) 24 (14) 12
Ulcer healing d 84 (86) 14
Major amputation d d 6 (2
Lack of walking capacity d 30 (50) 3 (5
Deceased d d d
Technically not feasible 2 (3) 14 (23) 12
Location of ulcer/vein graft not presenta d 4 (25) d
Open arteries on angiography d 8 (57) 5 (3
Others 1 (d) 1 (d) d
Unknown d 19 (55) 4 (1
Total 4 (1) 227 (38) 72
Note. Data ¼ n (%).
a In cases where percutaneous transluminal angioplasty was not feasipatients had no claudication or rest pain. In the absence of
symptoms, these patients may present late and, as a result,
vascular intervention is often considered too late in the
progress of a diabetic foot lesion. It is reported that 30e
50% of individuals with diabetes and foot ulcers already
have advanced tissue destruction at vascular evaluation and
are, therefore, considered unsuitable for intervention.31
We showed in the present study that the extent of tissue
destruction, aswell as ulcer progression, negatively affects the
probability of healing. This is in agreement with previous
studies.6,32 Irrespective of non-invasive vascular examination
results, it has been recommended to consider vascular imag-
ing and subsequent vascular intervention in diabetic patients
based on ischemic tissue destruction if no signs of healing are
noticed within 6 weeks of conservative treatment.33
There are commonly accepted exceptions for considering
angiography or revascularization in patients with PAD andhy/intervention.
led after minor
utation
Healed after major
amputation
Deceased
unhealed
Drop
out
Total
(16) 16 (16) 25 (25) d 100
(7) 32 (19) 96 (58) 1 (1) 166
(14) d d d 98
6) 14 (61) 3 (13) d 23
) 9 (15) 18 (30) d 60
d 26 (100) d 26
(20) 19 (32) 13 (22) d 60
6 (38) 6 (38) d 16
6) d 1 (7) d 14
d 3 (d) d 5
2) 5 (15) 6 (18) 34
(12) 101 (17) 197 (32) 1 (d) 602
ble.
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short life expectancy, pre-existing severe functional
impairment, and extensive tissue destruction.34 Similarly,
there were different reasons why angiography or further
revascularization was not done in our study. Signs of healing
and open arteries on angiography were factors for good
outcome where all patients healed without major ampu-
tation, with the exception of one patient who died before
healing. Fourteen patients had all arteries open in the lower
leg on angiography, and thirteen of them had a favourable
outcome. The number is, on the one hand, too small to
warrant reconsideration of the blood pressure criteria used
for screening.
On the other hand, deteriorated general condition prior
to angiography or vascular intervention, lack of vein graft,
and ulcer location as a reason for not performing vascular
intervention could be considered as factors predicting poor
outcome, as only 22% of patients healed without major
amputation. It is reported that up to 40% of patients
requiring below-knee bypass will have unusable or absent
vein graft in either extremity owing mainly to prior coronary
bypass or venous insufﬁciency.35 However, it remains un-
certain whether this unfavorable outcome in our study is
owing to the inability to improve arterial ﬂow to the foot or
to the existing co-morbidities.
Some methodological issues need to be considered when
evaluating the present study. As the patients included were
from a university hospital-based foot centre, a potential
negative selection bias has to be taken into account; how-
ever, it cannot be excluded that many patients with su-
perﬁcial ulcers were treated in primary healthcare without
the knowledge of the foot team. Comparison with other
studies is difﬁcult owing to differences in design, patient
selection, deﬁnitions, follow-up time, and other confound-
ing factors. Also, very few studies have been conducted on
diabetic patients with the same question in mind.17,21
Furthermore, this study is based on a predeﬁned protocol
regarding inclusion, evaluation, and follow up. However, the
decision for vascular intervention was at the discretion of
the vascular surgeon. It should also be recognized that
recruitment to the present study was stopped when mag-
netic resonance angiography and computed tomography
angiography became routine procedures.
In conclusion, diabetic patients with foot ulcer and severe
PAD considered not feasible for revascularization are not
excluded from healing without major amputation. The
present study indicates that the window of opportunity for
vascular intervention to achieve healing is strongly related
to co-morbidity, severity of PAD, and extent of tissue
destruction at the time of vascular evaluation. These fac-
tors, in addition to the anatomical criteria, should be
considered at decision-making for vascular intervention.
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